Qiming Venture Partners' Portfolio Company WeRide, a Global Pioneer in L4 Autonomous Driving, Completes Dual Primary Listing on Hong Kong Exchanges and Clearing Limited
WeRide is the Chinese autonomous driving company with the broadest international footprint and the most comprehensive product portfolio, and it is also the only technology company in the world whose products hold autonomous driving permits in seven countries.
Swipe Left for the English Version
On November 6, Beijing time, WeRide (NASDAQ: WRD, 00800.HK), a Qiming Venture Partners portfolio company and Nasdaq-listed company, completed its dual primary listing on the Hong Kong Stock Exchange.
As a global pioneer in L4 autonomous driving, WeRide boasts advanced technology, an excellent safety record, global reach, and solid partnerships.
WeRide currently has the broadest international footprint and most comprehensive product portfolio among Chinese autonomous driving companies, and is the only technology company in the world whose products hold autonomous driving permits in seven countries.
WeRide founder and CEO Tony Han (left) with Duane Kuang, Founding Managing Partner of Qiming Venture Partners (right)
WeRide offers a rich product mix spanning advanced driver assistance, robotaxi, robobus, robovan, and robosweeper — forming a comprehensive product matrix.
WeRide's autonomous driving products and solutions have already been deployed across more than 30 cities in 11 countries, including China, the UAE, Saudi Arabia, Switzerland, France, Singapore, and Japan.
Qiming Venture Partners' Portfolio Company WeRide Completes Dual Primary Listing on Hong Kong Stock Exchange
WeRide (NASDAQ: WRD, 0800.HK), a Qiming Venture Partners portfolio company, completed its dual primary listing on the Hong Kong Stock Exchange on November 6th.
As a global pioneer in L4-level autonomous driving, WeRide boasts advanced technology, excellent safety records, a global business coverage, and stable partnerships.
WeRide is a global autonomous driving company with the most extensive international business coverage and most diversified product mix. It is also the world's only technology company whose products have received autonomous driving permits in seven countries.
WeRide has a diversified product mix including Robotaxi, Robobus, Robovan, Robosweeper, and advanced driver assistance system.
WeRide's autonomous driving products and solutions have been used in over 30 cities across 11 countries such as China, the United Arab Emirates, Saudi Arabia, Switzerland, France, Singapore, and Japan.
往 期 回 顾
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have exited through listings on the NYSE, Nasdaq, Hong Kong Stock Exchange, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or through M&A. More than 80 portfolio companies have become recognized unicorns or super-unicorns.
Many of Qiming Venture Partners' portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ: BILI, 09626.HK), Zhihu (NYSE: ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ: HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ: WRD, 00800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ: ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ: SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), SinoCellTech (688520.SH), Harbour BioMed, Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.